| Date | Form | Description | Docs | XBRL | Pages |
| 03/08/17 | 8-K | Current report filing |
|
34 | |
| 03/06/17 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
79 | |
| 02/14/17 | 8-K | Current report filing |
|
6 | |
| 02/01/17 | CT ORDER | Confidential treatment order |
|
1 | |
| 01/27/17 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
|
82 |
| 01/19/17 | 8-K | Current report filing |
|
6 | |
| 01/11/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/11/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/10/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 |
Latest News & Events
Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
Read More...Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Read More...Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Read More...